LEUROSINE manufacturers
- LEUROSINE
-
- $0.01 / 1KG
-
2020-01-10
- CAS:23360-92-1
- Min. Order: 1KG
- Purity: 98%; 99%
- Supply Ability: 500g;1kg; 25kg
|
| LEUROSINE Basic information |
Product Name: | LEUROSINE | Synonyms: | Vinleurosine;4b-Acetoxy-3,4epoxy-3-hydroxy-16-methoxy-(4 H)-vincaleukoblast-6-ene-23,22dioic Acid Dimethyl Ester;(3'R,4'S)-3',4'-Oxy-4'-deoxyvincaleukoblastine;(3'alpha,4'alpha)-4'-Deoxy-3',4'-epoxyvincaleukoblastine;4'-Deoxy-3',4'-epoxyvincaleucoblastine, 9CI;4’-deoxy-3’,4’-epoxy-,(3’-alpha,4’-alpha)-vincaleukoblastin;4’-deoxy-3’,4’-epoxy-,(3’alpha,4’alpha)-vincaleukoblastin;amotin | CAS: | 23360-92-1 | MF: | C46H56N4O9 | MW: | 808.97 | EINECS: | | Product Categories: | | Mol File: | 23360-92-1.mol |  |
| LEUROSINE Chemical Properties |
Melting point | 202-205℃ | density | 1.39 | pka | 11.36±0.60(Predicted) |
RIDADR | 1544 | HazardClass | 6.1(a) | PackingGroup | II | Hazardous Substances Data | 23360-92-1(Hazardous Substances Data) | Toxicity | dog,LDLo,intraperitoneal,12mg/kg (12mg/kg),GASTROINTESTINAL: NAUSEA OR VOMITINGGASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA",Eksperimental'naya Onkologiya. Experimental Oncology. Vol. 9(5), Pg. 76, 1987. |
| LEUROSINE Usage And Synthesis |
Description | Vinqa rosea yields this complex dimeric alkaloid which forms colourless crystals
that are best purified by recrystallization from acetonitrile. It crystallizes with 8
moles of H20 and loses solvent when heated at In-5°C. It is also dextro?
rotatory with [α]26D + n° (CHCI3)’ A crystalline SUlphate is known which has
m.p. 238-242°C (dec.) and [α]D - 8.3° (MeOH). The N(b)-oxide is identical
with pleurosine (q.v.). | Uses | Antineoplastic. | Uses | Vinleurosine is an antitumor compound derived from Vinca Rosea. | Definition | ChEBI: Leurosine is a vinca alkaloid. | References | Svoboda., J. Amer. Pharm. Assoc., 47,834 (1959)
Neuss et al., J. Amer. Chern. Soc., 81,4754 (1959)
Revised structure:
Neuss et al., Tetrahedron Lett., 783 (1968)
|
| LEUROSINE Preparation Products And Raw materials |
|